Literature DB >> 20679586

Short-term effects of antipsychotic treatment on cerebral function in drug-naive first-episode schizophrenia revealed by "resting state" functional magnetic resonance imaging.

Su Lui1, Tao Li, Wei Deng, Lijun Jiang, Qizhu Wu, Hehan Tang, Qiang Yue, Xiaoqi Huang, Raymond C Chan, David A Collier, Shashwath A Meda, Godfrey Pearlson, Andrea Mechelli, John A Sweeney, Qiyong Gong.   

Abstract

CONTEXT: Most of what we know about antipsychotic drug effects is at the receptor level, distal from the neural system effects that mediate their clinical efficacy. Studying cerebral function in antipsychotic-naive patients with schizophrenia before and after pharmacotherapy can enhance understanding of the therapeutic mechanisms of these clinically effective treatments.
OBJECTIVE: To examine alterations of regional and neural network function in antipsychotic-naive patients with first-episode schizophrenia before and after treatment with second-generation antipsychotic medication.
DESIGN: Case-control study.
SETTING: Huaxi MR Research Center and Mental Health Centre of the West China Hospital. PARTICIPANTS: Thirty-four antipsychotic-naive patients with first-episode schizophrenia were scanned using gradient-echo echo-planar imaging while in a resting state. After 6 weeks of antipsychotic treatment, patients were rescanned. Thirty-four matched healthy control subjects were studied at baseline for comparison purposes. MAIN OUTCOME MEASURES: The amplitude of low-frequency fluctuations (ALFF) of blood oxygen level-dependent signals, believed to reflect spontaneous neural activity, was used to characterize regional cerebral function. Functional connectivity across brain regions was evaluated using a seed voxel correlation approach and an independent component analysis. Changes in these measures after treatment were examined to characterize effects of antipsychotic drugs on regional function and functional integration.
RESULTS: After short-term treatment with second-generation antipsychotic medications, patients showed increased ALFF, particularly in the bilateral prefrontal and parietal cortex, left superior temporal cortex, and right caudate nucleus. Increased regional ALFF was associated with a reduction of clinical symptoms, and a widespread attenuation in functional connectivity was observed that was correlated with increased regional ALFF.
CONCLUSIONS: We demonstrate for the first time, to our knowledge, that widespread increased regional synchronous neural activity occurs after antipsychotic therapy, accompanied by decreased integration of function across widely distributed neural networks. These findings contribute to the understanding of the complex systems-level effects of antipsychotic drugs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20679586     DOI: 10.1001/archgenpsychiatry.2010.84

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  183 in total

1.  Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives.

Authors:  Shashwath A Meda; Adrienne Gill; Michael C Stevens; Raymond P Lorenzoni; David C Glahn; Vince D Calhoun; John A Sweeney; Carol A Tamminga; Matcheri S Keshavan; Gunvant Thaker; Godfrey D Pearlson
Journal:  Biol Psychiatry       Date:  2012-03-07       Impact factor: 13.382

2.  General and specific functional connectivity disturbances in first-episode schizophrenia during cognitive control performance.

Authors:  Alex Fornito; Jong Yoon; Andrew Zalesky; Edward T Bullmore; Cameron S Carter
Journal:  Biol Psychiatry       Date:  2011-04-22       Impact factor: 13.382

3.  Linking inter-individual differences in neural activation and behavior to intrinsic brain dynamics.

Authors:  Maarten Mennes; Xi-Nian Zuo; Clare Kelly; Adriana Di Martino; Yu-Feng Zang; Bharat Biswal; F Xavier Castellanos; Michael P Milham
Journal:  Neuroimage       Date:  2010-10-23       Impact factor: 6.556

4.  Dynamic functional connectivity and its anatomical substrate reveal treatment outcome in first-episode drug-naïve schizophrenia.

Authors:  Zhe Zhang; Kaiming Zhuo; Qiang Xiang; Yi Sun; John Suckling; Jinhong Wang; Dengtang Liu; Yu Sun
Journal:  Transl Psychiatry       Date:  2021-05-12       Impact factor: 6.222

Review 5.  Neuroimaging markers of antipsychotic treatment response in schizophrenia: An overview of magnetic resonance imaging studies.

Authors:  Goda Tarcijonas; Deepak K Sarpal
Journal:  Neurobiol Dis       Date:  2018-06-25       Impact factor: 5.996

6.  Anatomical distance affects functional connectivity in patients with schizophrenia and their siblings.

Authors:  Shuixia Guo; Lena Palaniyappan; Bo Yang; Zhening Liu; Zhimin Xue; Jianfeng Feng
Journal:  Schizophr Bull       Date:  2013-11-26       Impact factor: 9.306

7.  Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia.

Authors:  Shashwath A Meda; Gualberto Ruaño; Andreas Windemuth; Kasey O'Neil; Clifton Berwise; Sabra M Dunn; Leah E Boccaccio; Balaji Narayanan; Mohan Kocherla; Emma Sprooten; Matcheri S Keshavan; Carol A Tamminga; John A Sweeney; Brett A Clementz; Vince D Calhoun; Godfrey D Pearlson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

Review 8.  Psychoradiology: The Frontier of Neuroimaging in Psychiatry.

Authors:  Su Lui; Xiaohong Joe Zhou; John A Sweeney; Qiyong Gong
Journal:  Radiology       Date:  2016-11       Impact factor: 11.105

9.  Brain grey-matter volume alteration in adult patients with bipolar disorder under different conditions: a voxel-based meta-analysis

Authors:  Xiuli Wang; Qiang Luo; Fangfang Tian; Bochao Cheng; Lihua Qiu; Song Wang; Manxi He; Hongming Wang; Mingjun Duan; Zhiyun Jia
Journal:  J Psychiatry Neurosci       Date:  2019-03-01       Impact factor: 6.186

10.  Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics in first-episode schizophrenia.

Authors:  Jeffrey R Bishop; James L Reilly; Margret S H Harris; Shitalben R Patel; Rick Kittles; Judith A Badner; Konasale M Prasad; Vishwajit L Nimgaonkar; Matcheri S Keshavan; John A Sweeney
Journal:  Psychopharmacology (Berl)       Date:  2014-08-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.